Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Peer Reviewed
See detailHeadache
FUMAL, Arnaud ULg; Schoenen, Jean ULg

in Kopf, A; Nilesh (Eds.) Guide to pain management in low-ressources settings (2011)

Detailed reference viewed: 4 (0 ULg)
Full Text
See detailHeadache
Schoenen, Jean ULg; MAERTENS DE NOORDHOUT, Alain ULg

in Wall, P. D.; Melzack, R. (Eds.) Textbook of Pain (1994)

Detailed reference viewed: 4 (2 ULg)
See detailHeadache
Schoenen, Jean ULg; Sandór, P.

in Melzack, R.; Wall, P. D. (Eds.) Handbook of pain management (2003)

Detailed reference viewed: 4 (1 ULg)
See detailHeadache
Schoenen, Jean ULg; Sandór, P.

in Wall, P. D.; Melzack, R. (Eds.) Textbook of Pain (1999)

Detailed reference viewed: 2 (0 ULg)
Peer Reviewed
See detailHeadache cases
MAGIS, Delphine ULg

Conference (2005)

Detailed reference viewed: 6 (0 ULg)
See detailHeadache tutorial
Russel, M. B.; Nielsen, K. D.; Rasmussen, C. et al

in Paiva, T.; Penzel, T. (Eds.) European Neurological Network (2000)

Detailed reference viewed: 5 (1 ULg)
Peer Reviewed
See detailHeadache tutorial.
Russell, M. B.; Nielsen, K. D.; Rasmussen, C. et al

in Studies in Health Technology & Informatics (2000), 78

The headache multimedia educational tool for the general practitioners, consists of five different modules, i.e. classification, clinical data, headache tutorial, diagnostic headache diary and ... [more ▼]

The headache multimedia educational tool for the general practitioners, consists of five different modules, i.e. classification, clinical data, headache tutorial, diagnostic headache diary and nomenclature. It is possible to move between the modules both vertically and horizontally. This paper concerns the headache tutorial. It consist of case records that the user can test his diagnostic abilities on. Each case record is subdivided into an interview by the physician, physical and neurological examination, laboratory test, sum of positive diagnostic elements, suggestions of diagnoses and management. A total of 12 case records are provided. The system will be available on a CD-ROM. [less ▲]

Detailed reference viewed: 16 (1 ULg)
Full Text
Peer Reviewed
See detailHeadache with focal neurological signs or symptoms: a complicated differential diagnosis
Schoenen, Jean ULg; Sandor, P. S.

in Lancet Neurology (2004), 3(4), 237-245

Headache syndromes can be associated with focal neurological symptoms or signs. Good knowledge of primary headaches, a detailed history and a thorough clinical examination are prerequisites for their ... [more ▼]

Headache syndromes can be associated with focal neurological symptoms or signs. Good knowledge of primary headaches, a detailed history and a thorough clinical examination are prerequisites for their differential diagnosis. The neurological symptoms produced by the migraine aura are the most characteristic and recognisable. However, structural lesions, such as vascular malformations, can produce similar symptoms to migraine with aura, which highlights that paraclinical investigations are necessary in most patients with headache and focal neurological symptoms. In this review, we provide an overview of the differential diagnosis of the most common headache disorders with focal neurological symptoms or signs to refresh the practising neurologist's differential diagnostic knowledge for the clinical situation and to aid the teaching of neurology residents. [less ▲]

Detailed reference viewed: 61 (2 ULg)
Full Text
Peer Reviewed
See detailHeadache: spreading from molecules to patients
Schoenen, Jean ULg; Coppola, G.

in Lancet Neurology (2010), 9

Detailed reference viewed: 64 (4 ULg)
Full Text
Peer Reviewed
See detailHealing effect of ketanserin on chronic leg ulcers in patients with diabetes.
Quatresooz, Pascale ULg; Kharfi, M.; Paquet, Philippe ULg et al

in Journal of the European Academy of Dermatology & Venereology (2006), 20(3), 277-81

BACKGROUND: The treatment of chronic leg ulcers remains a stubborn problem in many patients. Topical 2% ketanserin ointment, a 5HT2-serotoninergic blocking agent, has been reported to improve healing of ... [more ▼]

BACKGROUND: The treatment of chronic leg ulcers remains a stubborn problem in many patients. Topical 2% ketanserin ointment, a 5HT2-serotoninergic blocking agent, has been reported to improve healing of decubitus, venous, diabetic and ischaemic ulcers. METHOD: The present double-blind intra-individual comparative study was performed in 12 women with diabetes presenting with at least two similar leg ulcers. In each subject, the two lesions were randomly assigned to be treated for 8 weeks by 2% ketanserin ointment or its unmedicated vehicle. OBJECTIVE: assessments of the dynamics of wound healing were performed using computerized morphometry. Evaluations were performed at 2-week intervals for 8 weeks. RESULTS: A significant decrease in relative wound area was observed on the ketanserin-treated ulcers compared with the placebo group. CONCLUSION: Topical ketanserin is a valuable therapy for difficult-to-treat leg ulcers. [less ▲]

Detailed reference viewed: 36 (3 ULg)
Full Text
Peer Reviewed
See detailHealth care cost containment.
Van Damme, Hendrik ULg; Michel, L.

in Acta Chirurgica Belgica (2008), 108(1), 2-3

Detailed reference viewed: 12 (4 ULg)
Full Text
Peer Reviewed
See detailHealth claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science
Bruyère, Olivier ULg; Avouac, Bernard; Richette, Pascal et al

in Current Medical Research & Opinion (2012), 28(4), 611-6

Abstract Introduction: In 2006, the European Parliament and Council issued a regulation (No. 1924/2006) for the nutrition and health claims made on foods, including food supplements. According to the ... [more ▼]

Abstract Introduction: In 2006, the European Parliament and Council issued a regulation (No. 1924/2006) for the nutrition and health claims made on foods, including food supplements. According to the regulation, the use of nutrition and health claims shall only be permitted if the substance in respect of which the claim is made has been shown to have a beneficial nutritional or physiological effect. In the field of joint and cartilage health, there is no clear scientific-based definition of the nature of such a beneficial nutritional or physiological effect. The objective of this paper is to scientifically define the possible content of health claims related to joint and cartilage health and to provide scientific guidelines for the design of clinical studies which need to be adopted to substantiate such health claims. Methods: Literature review up to September 2011 followed by a consensus expert discussion organized by the Group for the Respect of Ethics and Excellence in Science (GREES). Results: In line with the general principles of the PASSCLAIM and the Codex recommendations, the GREES identified four acceptable health claims related to joint and cartilage health based on the effects on discomfort, joint and cartilage structural integrity or risk factors for joint and cartilage diseases. The GREES considers that randomized controlled trials on a relevant outcome is the best design to assess health claims. Moreover, animal studies could also be of interest to substantiate some health claims, to assess the clinical relevance of endpoints used in human studies or to extrapolate data obtained in patients to the target (apparently) healthy population. Conclusion: According to the methodology and biomarkers used in the study and whether or not additional animal studies are provided to support the claim, various health claims can be acceptable in the field of joint and cartilage health. [less ▲]

Detailed reference viewed: 22 (6 ULg)
See detailHealth claims for nutriceuticals products in the field of cartilage and joint
Bruyère, Olivier ULg

Conference (2012, March 23)

Detailed reference viewed: 5 (0 ULg)
See detailHealth CoP : communautés de pratique dans le domaine de la santé
Denis, Brigitte ULg; Snoeck, Céline ULg; Grana-Monteirin, Casto ULg

Report (2010)

Ce rapport (privé) décrit les actions menées dans le cadre du projet Health CoP. http://www.crifa.ulg.ac.be/projets/healthcop/

Detailed reference viewed: 81 (11 ULg)
Full Text
Peer Reviewed
See detailHealth Economics Analyses in Osteoporosis
Hiligsmann, Mickaël ULg; Reginster, Jean-Yves ULg

in Arinoviche Schenker, Roberto; Arriagada Maldini, Marina (Eds.) Temas de osteoporosis y otras enfermedades oseas (2013)

Detailed reference viewed: 38 (20 ULg)
Full Text
Peer Reviewed
See detailHealth economics in osteoarthritis
Hiligsmann, Mickaël ULg; Cooper, Cyrus; Arden, Nigel et al

in Osteoporosis International (2013, April), 24(Suppl.1), 79-80

Detailed reference viewed: 12 (1 ULg)
Full Text
Peer Reviewed
See detailHealth economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Hiligsmann, Mickaël ULg; Cooper, Cyrus; Arden, Nigel et al

in Seminars in Arthritis & Rheumatism (2013), 43(3), 303-313

OBJECTIVES: There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy. METHODS: The ESCEO expert working group met to discuss ... [more ▼]

OBJECTIVES: There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy. METHODS: The ESCEO expert working group met to discuss the epidemiological and economic evidence that justifies the increasing concern of the impact of this disease and reviewed the current state-of-the-art in health economic studies in this field. RESULTS: OA is a debilitating disease; it is increasing in frequency and is associated with a substantial and growing burden on society, in terms of both burden of illness and cost of illness. Economic evaluations in this field are relatively rare, and those that do exist, show considerable heterogeneity of methodological approach (such as indicated population, comparator, decision context and perspective, time horizon, modeling and outcome measures used). This heterogeneity makes comparisons between studies problematic. CONCLUSIONS: Better adherence to guidelines for economic evaluations is needed. There was strong support for the definition of a reference case and for what might constitute "standard optimal care" in terms of best clinical practice, for the control arms of interventional studies. [less ▲]

Detailed reference viewed: 17 (6 ULg)